Topic
Esmo
Recent coverage of Esmo from across the web.
-
Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer -
ESMO: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer -
New targeted therapy shows promising early results in advanced pancreatic cancer
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow